PARP inhibitors: their applications and efficacy against prostate cancer

2022 ASCO Genitourinary Cancers Symposium Research Updates Webinar with Dr. Alexandra SokolovaПодробнее

PARP Inhibitors for Prostate CancerПодробнее

Role of PARP Inhibitors in Prostate CancerПодробнее

Targeting Advanced Prostate Cancer with PARP inhibitors: Who, When and How?Подробнее

The Role of PARP Inhibitors in Advanced Prostate CancerПодробнее

Dr. Higano Discusses PARP Inhibitors in Prostate CancerПодробнее

Choosing the correct PARP inhibitor for prostate cancerПодробнее

PARP inhibitors and their evolving role for the treatment of prostate cancerПодробнее

Dr. Dorff Discusses the Use of PARP Inhibitors in Prostate CancerПодробнее

PARP Inhibitors in Advanced Prostate Cancer CareПодробнее

Current perspectives from clinical trials using PARP inhibitors for prostate cancerПодробнее

Dr. Morgan on the Role of PARP Inhibitors in Prostate CancerПодробнее

The Role of Genetic Testing and PARP Inhibitors (2022)Подробнее

Dr. Hussain Discusses PARP Inhibitors in Prostate CancerПодробнее

Which mutations benefit most from PARP inhibitors in prostate cancer?Подробнее

When is the optimal time to use PARP inhibitors in prostate cancer patients?Подробнее

PARP Inhibitors for Prostate Cancer with Moshe Ornstein, MDПодробнее

PARP inhibitors in advanced prostate cancerПодробнее

Where can PARP inhibitors be usedПодробнее

LuPARP: 177Lu-PSMA-617 and PARP inhibitor combination for prostate cancerПодробнее